SYSTEM AND METHOD FOR OSTEOPOROSIS ASSESSMENT AND MEDICATION ADHERENCE EVALUATION

• US 20070208597A1
• Filed: 03/09/2007
• Published: 09/06/2007
• Est. Priority Date: 12/02/2004
• Status: Abandoned Application

• Current Assignee: Chris Recknor, Stephanie Grant
• Original Assignee: Chris Recknor, Stephanie Grant
• Inventors: Recknor, Chris, Grant, Stephanie
• Application Number:
  US11/684,481
• Publication Number:
  US 20070208597A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/30 relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

An osteoporosis assessment system and method. The system and method generally include an input device that can be a computer that can be further connected to a network. The system can therefore be web-based. The system receives patient data and data related to osteoporosis. The method is implemented to correlate the patient data and the osteoporosis data and output is generated that personalizes the osteoporosis data to the patient based on the valued activities of the patient, so that the patient can understand his or her personal fracture risk assessment, therapy needs determination and therapy progress measurement. Therapy and treatment recommendations can also be generated.

Claims

1. A method, comprising:

identifying a patient;

applying a first criteria set to the identified patient;

determining whether the patient has maintained within compliance as determined by the first criteria set; and

applying a second criteria set to the identified patient.

2. The method as claimed in claim 1 wherein applying the first criteria set further comprises having the identified patient provide a history of whether the identified patient has used a medication type.

3. The method as claimed in claim 2 further comprising soliciting responses from the identified patient.

4. A method, comprising:

identifying a patient;

optionally soliciting responses based on a first criteria set from the patient if the patient has no prior use of a first medication;

soliciting responses based on a second criteria set from the patient on the use of the first medication;

determining whether the patient has maintained compliance with the first medication;

soliciting responses based on a third criteria set if the patient has been non-compliant; and

soliciting responses based on a fourth criteria set if the patient has been compliant.

5. The method as claimed in claim 4 wherein the first criteria set includes questions based on at least one of no prior use and no history of taking the first medication.

6. The method as claimed in claim 4 wherein the second criteria set includes questions based on at least on of current use and history of taking the first medication type.

7. The method as claimed in claim 4 wherein the third criteria set includes questions based on non-adherence or dissatisfaction in taking the first medication.

8. The method as claimed in claim 4 wherein the fourth criteria set includes questions based on adherence to the medication.

9. The method as claimed in claim 4 wherein the medication is bone building medication.

10. The method as claimed in claim 8 wherein the medication is bone building medication.

11. The method as claimed in claim 10 wherein the bone building medication is chosen from the group consisting of:

Fosamax®

, Actonel®

MAS, Evista®

MAS, Ibandronate MAS, Didronel®

MAS, Miacalcin®

MAS, Forteo®

MAS, Zometa®

MAS and Aredia®

MAS.

12. The method as claimed in claim 4 further comprising allowing a first period of time to pass between optionally soliciting responses based on a first criteria set from the patient if the patient has no prior use of a first medication and soliciting responses based on a second criteria set from the patient on the use of the first medication.

13. The method as claimed in claim 4 further comprising allowing a second period of time to pass between soliciting responses based on a second criteria set from the patient on the use of the first medication and soliciting responses based on a third criteria set if the patient has been non-compliant and soliciting responses based on a fourth criteria set if the patient has been compliant.

14. The method as claimed in claim 4 wherein the first set of criteria includes patient risk factors

15. The method as claimed in claim 14 wherein the risk factors include lifestyle and perception risk.

16. The method as claimed in claim 14 wherein the risk factors include medication risk.

17. The method as claimed in claim 14 wherein the risk factors include awareness risk.

18. The method as claimed in claim 14 wherein the risk factors include cognition risk.